“To reduce death and disability from thrombotic diseases by conducting research into the pathogenesis, prevention, diagnosis and treatment of thrombosis and vascular disease.”
- To carry out basic, clinical, and epidemiologic research in thrombosis, atherosclerosis, and cardiovascular disease including venous thrombosis, pulmonary embolism, coronary heart disease, arrhythmias, congestive heart failure, cardiac thromboembolism, cerebrovascular disease, and peripheral vascular disease. The scope of the research is broad, extending from the basic laboratory to the bedside and beyond into the local, national and international communities. A unique feature of TaARI is that the research is driven by clinically relevant problems which, if solved, have the potential to be translated rapidly into more efficacious and cost-effective patient care or preventive strategies.
- To act as a resource and methods centre for the design, execution and analysis of local, national and international clinical trials and epidemiologic studies in cardiovascular disease, and for other clinical programmes which are part of the strategic plan of the Hamilton Health Sciences.
- To develop joint research programmes with scientists and clinicians based at the Hamilton Health Sciences, Cancer Care Ontario (formerly the Ontario Cancer Treatment and Research Foundation), Hamilton Regional Cancer Centre and with investigators based at other universities in Canada and abroad.
- To encourage and facilitate clinical research among members of the medical and allied health professional staff at the Hamilton Health Sciences.
- To obtain research funding from statutory granting agencies, from industry, and through partnerships with investors in the private sector.
- To patent and commercialize inventions through the Hamilton Civic Hospitals Research Development Corporation.
- To train graduate students, research fellows and other health professionals, both Canadian and international, in: Basic, applied and preventive research in hemostasis, thrombosis, atherosclerosis, cardiovascular disorders, bone disorders. and the methodology of clinical research.
- To provide a resource in clinical research methodology and laboratory research for members of the Hamilton Health Sciences and other hospitals affiliated with McMaster University.
- To organize international conferences and seminars on specific diseases or on methodologic issues.
- To organize public education seminars on important health issues related to the interests of the David Braley Research Institute. To make presentations to lay groups in the community on health topics of current interest.
We acknowledge with gratitude the financial support for research provided by the Heart and Stroke Foundations of Ontario and Canada, the Canadian Institute of Health Research, the Ontario Research and Development Challenge Fund (ORDCF), The National Cancer Institute of Canada, the Hamilton Health Sciences, the Hamilton Health Foundation, McMaster University, and the Ronald K. Fraser Foundation. We also acknowledge the extensive support we have received from several pharmaceutical companies. We are particularly grateful to the Ontario Research and Development Challenge Fund for their support to encourage the commercialization of our research.
- Heart and Stroke Foundation (HSFO)
- Canadian Institutes of Health Research (CIHR)
- Ministry of Health of Ontario
- Ontario Research Fund (ORF) (formerly ORDCF)
- Canadian Cancer Society Research Institute
- Hamilton Health Sciences
- Hamilton Health Sciences Foundation
- McMaster University